207 related articles for article (PubMed ID: 36434556)
1. Artificial intelligence to guide precision anticancer therapy with multitargeted kinase inhibitors.
Singha M; Pu L; Stanfield BA; Uche IK; Rider PJF; Kousoulas KG; Ramanujam J; Brylinski M
BMC Cancer; 2022 Nov; 22(1):1211. PubMed ID: 36434556
[TBL] [Abstract][Full Text] [Related]
2. CancerOmicsNet: a multi-omics network-based approach to anti-cancer drug profiling.
Pu L; Singha M; Ramanujam J; Brylinski M
Oncotarget; 2022; 13():695-706. PubMed ID: 35601606
[TBL] [Abstract][Full Text] [Related]
3. Unlocking the Potential of Kinase Targets in Cancer: Insights from CancerOmicsNet, an AI-Driven Approach to Drug Response Prediction in Cancer.
Singha M; Pu L; Srivastava G; Ni X; Stanfield BA; Uche IK; Rider PJF; Kousoulas KG; Ramanujam J; Brylinski M
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627077
[TBL] [Abstract][Full Text] [Related]
4. Research Trends in the Application of Artificial Intelligence in Oncology: A Bibliometric and Network Visualization Study.
Wu T; Duan Y; Zhang T; Tian W; Liu H; Deng Y
Front Biosci (Landmark Ed); 2022 Aug; 27(9):254. PubMed ID: 36224012
[TBL] [Abstract][Full Text] [Related]
5. Artificial intelligence in oncology.
Shimizu H; Nakayama KI
Cancer Sci; 2020 May; 111(5):1452-1460. PubMed ID: 32133724
[TBL] [Abstract][Full Text] [Related]
6. Artificial Intelligence in Cancer Research and Precision Medicine.
Bhinder B; Gilvary C; Madhukar NS; Elemento O
Cancer Discov; 2021 Apr; 11(4):900-915. PubMed ID: 33811123
[TBL] [Abstract][Full Text] [Related]
7. Predicting gene mutation status via artificial intelligence technologies based on multimodal integration (MMI) to advance precision oncology.
Shao J; Ma J; Zhang Q; Li W; Wang C
Semin Cancer Biol; 2023 Jun; 91():1-15. PubMed ID: 36801447
[TBL] [Abstract][Full Text] [Related]
8. De novo Prediction of Cell-Drug Sensitivities Using Deep Learning-based Graph Regularized Matrix Factorization.
Ren S; Tao Y; Yu K; Xue Y; Schwartz R; Lu X
Pac Symp Biocomput; 2022; 27():278-289. PubMed ID: 34890156
[TBL] [Abstract][Full Text] [Related]
9. Artificial intelligence-assisted selection and efficacy prediction of antineoplastic strategies for precision cancer therapy.
Zhang Z; Wei X
Semin Cancer Biol; 2023 May; 90():57-72. PubMed ID: 36796530
[TBL] [Abstract][Full Text] [Related]
10. Artificial Intelligence for Precision Oncology.
Bhalla S; Laganà A
Adv Exp Med Biol; 2022; 1361():249-268. PubMed ID: 35230693
[TBL] [Abstract][Full Text] [Related]
11. Artificial intelligence for assisting cancer diagnosis and treatment in the era of precision medicine.
Chen ZH; Lin L; Wu CF; Li CF; Xu RH; Sun Y
Cancer Commun (Lond); 2021 Nov; 41(11):1100-1115. PubMed ID: 34613667
[TBL] [Abstract][Full Text] [Related]
12. Artificial intelligence in oncology: Path to implementation.
Chua IS; Gaziel-Yablowitz M; Korach ZT; Kehl KL; Levitan NA; Arriaga YE; Jackson GP; Bates DW; Hassett M
Cancer Med; 2021 Jun; 10(12):4138-4149. PubMed ID: 33960708
[TBL] [Abstract][Full Text] [Related]
13. Artificial intelligence and digital biomarker in precision pathology guiding immune therapy selection and precision oncology.
Huss R; Raffler J; Märkl B
Cancer Rep (Hoboken); 2023 Jul; 6(7):e1796. PubMed ID: 36813293
[TBL] [Abstract][Full Text] [Related]
14. Artificial intelligence in oncology: From bench to clinic.
Elkhader J; Elemento O
Semin Cancer Biol; 2022 Sep; 84():113-128. PubMed ID: 33915289
[TBL] [Abstract][Full Text] [Related]
15. Artificial intelligence in digital pathology - new tools for diagnosis and precision oncology.
Bera K; Schalper KA; Rimm DL; Velcheti V; Madabhushi A
Nat Rev Clin Oncol; 2019 Nov; 16(11):703-715. PubMed ID: 31399699
[TBL] [Abstract][Full Text] [Related]
16. Artificial intelligence in cancer immunotherapy: Applications in neoantigen recognition, antibody design and immunotherapy response prediction.
Li T; Li Y; Zhu X; He Y; Wu Y; Ying T; Xie Z
Semin Cancer Biol; 2023 Jun; 91():50-69. PubMed ID: 36870459
[TBL] [Abstract][Full Text] [Related]
17. Drug Repositioning via Graph Neural Networks: Identifying Novel JAK2 Inhibitors from FDA-Approved Drugs through Molecular Docking and Biological Validation.
Yasir M; Park J; Han ET; Park WS; Han JH; Chun W
Molecules; 2024 Mar; 29(6):. PubMed ID: 38542998
[TBL] [Abstract][Full Text] [Related]
18. Artificial intelligence-based risk stratification, accurate diagnosis and treatment prediction in gynecologic oncology.
Jiang Y; Wang C; Zhou S
Semin Cancer Biol; 2023 Nov; 96():82-99. PubMed ID: 37783319
[TBL] [Abstract][Full Text] [Related]
19. A primer on applying AI synergistically with domain expertise to oncology.
Kim J; Kusko R; Zeskind B; Zhang J; Escalante-Chong R
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188548. PubMed ID: 33901609
[TBL] [Abstract][Full Text] [Related]
20. AI (Artificial Intelligence) and Hypertension Research.
Mueller FB
Curr Hypertens Rep; 2020 Aug; 22(9):70. PubMed ID: 32852654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
